Encrantz, a director at Sight Sciences, has purchased shares of the company valued at $68,793. This transaction reflects Encrantz's investment in the company, signaling confidence in its future performance. The purchase was disclosed in a filing with the appropriate regulatory authorities, as required for corporate insiders.
Related Articles
Don't miss out on breaking stories and in-depth articles.